Over time the body naturally produces fewer growth factors for repair and rebuilding. Umbilical Cord Tissue Products encourage the rebuilding and repair of injury sites and optimizes the body's innate healing potential. Umbilical Cord Tissues are Undifferentiated cells that have the ability to self replicate and some may change into any specific cell type in the body. These cells are given intravenously or injected directly into an area of injury. Umbilical Cord Tissue have a natural "homing ability "to go to areas of injury and inflammation due to signals that are released by injured cells. After they are injected and they reach the target tissue, they begin to repair the injury or disease by releasing growth factors and immune modulators that assist in the body's natural repair process and encourage growth and tissue renewal. Although some patients may experience results within the first 24 to 48 hours and continued relief and function following and injection we typically give the Umbilical Cord Tissue a full 6 months to one year to measure their effectiveness.
Root Medical uses products manufactured by Cellulum Core and Vitti Labs. These labs only accept bio-ethically donated birth tissue from healthy consenting donor volunteers noninvasively and painlessly who have passed a comprehensive medical background check, including genetic testing and blood screening. These products are human Cell and Tissue products (HCT/Ps) derived from human placental, amniotic fluid or umbilical cord tissue that is recovered from the donors who have full-term, live, C-section births. These products have also undergone extensive testing and screening to ensure safety and quality including infectious disease testing. They are processed in sterile ISO cleanroom conditions using aseptic techniques to prevent contamination of the tissues.
Each product is stored in a Cryotank filled with liquid Nitrogen, at 80 degrees below zero. Vitti-Pure is regulated by the FDA as a HCT/P under CFR Part 1271 Section 361 of The Public Health Service Act. No adverse clinical reactions have been reported.